AI is already accelerating drug discovery and health delivery. It has great potential to accelerate research, workflow and processes, and even reengineer entire healthcare systems. But what challenges must be addressed first? Shahram Ebadollahi and Ann Aerts share the ideas they discussed at the Intelligent Health summit in Basel this week.

Novartis’ Don Ganem tapped as a scientific advisor for the Chan Zuckerberg Biohub

Lazala has been recognized by Hispanic Executive magazine for her commitment to mentoring students and colleagues.

Researchers at Novartis are combining modern techniques with an old approach to drug discovery and getting surprising results.

Genome editing advances drug discovery in biomedical research.

Accomplished female scientists at Novartis share their wisdom born from difficult moments in life.